TONY Investment

Todoc is a technology leader in the field of neural prosthesis and neuromodulation in Korea, specializing in the development of advanced cochlear implant systems. The company aims to address the high costs associated with cochlear implants, which have traditionally limited access to hearing restoration for individuals in developing countries. Todoc's innovative approach involves automated micro-machining processes to manufacture neural electrodes, significantly reducing production costs to one-tenth of conventional methods. This advancement not only makes cochlear implants more affordable but also enhances their performance by offering a wider range of sound capabilities. The company's 32-channel cochlear implant system stands out with the highest number of channels available, utilizing wireless transmission technology for effective data transfer. Todoc's mission is to expand the global cochlear implant market and establish itself as a leader in the Brain-Machine Interface sector through its superior neural interface technology.

ArtTogether is based in Seoul, South Korea.

Innospace is an aerospace and defense company focused on developing hybrid rocket-powered small satellite launch vehicles. The company aims to provide cost-effective, low-latency, and environmentally friendly launch services tailored for the small satellite market. By utilizing innovative hybrid rocket technology, Innospace is committed to delivering reliable solutions for satellite deployment, catering to the increasing demand for efficient access to space.

Operator of cell company intended to provide hydrogen fuel cells. The company specializes in fuel cells with hydrogen and develops cell packs that can perform in extreme environments, enabling users with a source of energy even in bad conditions.

WAUG Travel Inc. is a travel activity booking platform based in Seoul, South Korea, founded in 2015. The company provides a user-friendly interface that allows travelers to create itineraries and book various activities and experiences globally through both mobile and web applications. WAUG aims to simplify the travel planning process by offering a diverse range of fun things to do, making it easier for users to discover and reserve their desired activities while traveling.

Operator of a software intelligence company designed to increase efficiency and profitability and provide value-added data-driven services. The company's platform provides a complex and detailed big data analysis by using the demographic information of the client, enabling businesses to have bulk customer database registration, contact number group management, active clients' contact number filtering, unsubscribed client management and overall membership management services.

S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, founded in 2019. The company focuses on researching and developing health applications and platform technologies aimed at treating a variety of diseases. Its product lineup includes SAT-001, an application for eye disease; SAT-002, designed for neurological conditions; SAT-003, which aids in cancer recovery and treatment; and SAT-008, a public crisis application addressing social issues. In addition to these applications, S-Alpha Therapeutics also develops therapeutic devices that support its digital health solutions. The company aims to provide innovative treatment methods for areas such as ophthalmology, neuropsychiatry, cancer, and immunology, addressing unmet medical needs through digital approaches.

S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, founded in 2019. The company focuses on researching and developing health applications and platform technologies aimed at treating a variety of diseases. Its product lineup includes SAT-001, an application for eye disease; SAT-002, designed for neurological conditions; SAT-003, which aids in cancer recovery and treatment; and SAT-008, a public crisis application addressing social issues. In addition to these applications, S-Alpha Therapeutics also develops therapeutic devices that support its digital health solutions. The company aims to provide innovative treatment methods for areas such as ophthalmology, neuropsychiatry, cancer, and immunology, addressing unmet medical needs through digital approaches.